GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » vTv Therapeutics Inc (NAS:VTVT) » Definitions » E10

VTVT (vTv Therapeutics) E10 : $-43.21 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is vTv Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

vTv Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.880. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-43.21 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-01-18), vTv Therapeutics's current stock price is $14.05. vTv Therapeutics's E10 for the quarter that ended in Sep. 2024 was $-43.21. vTv Therapeutics's Shiller PE Ratio of today is .


vTv Therapeutics E10 Historical Data

The historical data trend for vTv Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

vTv Therapeutics E10 Chart

vTv Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -46.23

vTv Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.40 -46.23 -44.75 -43.91 -43.21

Competitive Comparison of vTv Therapeutics's E10

For the Biotechnology subindustry, vTv Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


vTv Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, vTv Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where vTv Therapeutics's Shiller PE Ratio falls into.



vTv Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, vTv Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.88/133.0289*133.0289
=-0.880

Current CPI (Sep. 2024) = 133.0289.

vTv Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201412 -9.405 99.070 -12.629
201503 -11.963 99.621 -15.975
201506 -53.310 100.684 -70.436
201509 -19.600 100.392 -25.972
201512 -14.000 99.792 -18.663
201603 -16.800 100.470 -22.244
201606 -18.800 101.688 -24.594
201609 -16.400 101.861 -21.418
201612 -16.800 101.863 -21.940
201703 -17.600 102.862 -22.762
201706 -16.400 103.349 -21.110
201709 -15.200 104.136 -19.417
201712 -17.600 104.011 -22.510
201803 -12.000 105.290 -15.162
201806 -12.400 106.317 -15.516
201809 -2.400 106.507 -2.998
201812 -4.000 105.998 -5.020
201903 -10.400 107.251 -12.900
201906 -4.000 108.070 -4.924
201909 -5.200 108.329 -6.386
201912 -5.200 108.420 -6.380
202003 -4.400 108.902 -5.375
202006 -2.800 108.767 -3.425
202009 -1.200 109.815 -1.454
202012 0.800 109.897 0.968
202103 -3.200 111.754 -3.809
202106 -0.400 114.631 -0.464
202109 -0.800 115.734 -0.920
202112 -4.400 117.630 -4.976
202203 -4.000 121.301 -4.387
202206 -1.600 125.017 -1.703
202209 -2.000 125.227 -2.125
202212 -2.400 125.222 -2.550
202303 -2.160 127.348 -2.256
202306 -2.690 128.729 -2.780
202309 -3.190 129.860 -3.268
202312 -1.670 129.419 -1.717
202403 -1.170 131.776 -1.181
202406 -0.810 132.554 -0.813
202409 -0.880 133.029 -0.880

Add all the adjusted EPS together and divide 10 will get our e10.


vTv Therapeutics  (NAS:VTVT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


vTv Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of vTv Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


vTv Therapeutics Business Description

Traded in Other Exchanges
Address
3980 Premier Drive, Suite 310, High Point, NC, USA, 27265
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Executives
Paul J Sekhri director, officer: President and CEO C/O VEEVA SYSTEMS INC., 4637 CHABOT DRIVE, SUITE 210, PLEASANTON CA 94588
Steven L. Tuch officer: Chief Financial Officer C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265
John A Fry director C/O DELAWARE INVESTMENTS, 2005 MARKET ST. 34TH FL., PHILADELPHIA PA 19103
Jonathan Isaacsohn director C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265
Fahed Al-marzooqi director AL KHATEM TOWER, ABU DHABI GLOBAL MARKET, ABU DHABI C0 00000
Keith R. Harris director C/O MEIRAGTX - US, 430 EAST 29TH STREET, 10TH FLOOR, NEW YORK NY 10016
Hersh Kozlov director WOLF BLOCK SCHORR & SOLIS, 1940 RTE 70 E, CHERRY HILL NJ 08003
Howard L. Weiner director 4170 MENDENHALL OAKS PKWY, HIGH POINT NC 27265
Chandresh Harjivan director C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265
Al-nahyan Tahnoon Bin Zayed S. 10 percent owner OFFICE 2458, FLOOR 24, AL-SILA TOWER, ABU DHABI C0 00000
G42 Investments Ai Holdings Rsc Ltd. director, 10 percent owner OFFICE 801, FLOOR 8, AL KHATEM TOWER, ABU DHABI C0 00000
Barry K. Brown officer: Chief Accounting Officer C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265
Rich S. Nelson director, officer: Acting Chief Executive Officer C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, HIGH POINT NC 27265
Ronald O Perelman 10 percent owner 35 EAST 62ND STREET, NEW YORK NY 10021
Deepa Prasad director, officer: President and CEO C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT NC 27265

vTv Therapeutics Headlines

From GuruFocus